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ABSTRACT
Antimycins are an extended family of depsipeptides that are made by filamentous
actinomycete bacteria and were first isolated more than 60 years ago. Recently, an-
timycins have attracted renewed interest because of their activities against the anti-
apoptotic machineries inside human cells which could make them promising anti-
cancer compounds. The biosynthetic pathway for antimycins was recently char-
acterised but very little is known about the organisation and regulation of the an-
timycin (ant) gene cluster. Here we report that the ant gene cluster in Streptomyces
albus is organized into four transcriptional units; the antBA, antCDE, antGF and
antHIJKLMNO operons. Unusually for secondary metabolite clusters, the antG and
antH promoters are regulated by an extracytoplasmic function (ECF) RNA poly-
merase sigma factor named σAntA which represents a new sub-family of ECF σ fac-
tors that is only found in antimycin producing strains. We show that σAntA controls
production of the unusual precursor 3-aminosalicylate which is absolutely required
for the production of antimycins. σAntA is highly conserved in antimycin produc-
ing strains and the−10 and−35 elements at the σAntA regulated antG and antH
promoters are also highly conserved suggesting a common mechanism of regula-
tion. We also demonstrate that altering the C-terminal Ala-Ala residues found in all
σAntA proteins to Asp-Asp increases expression of the antFG and antGHIJKLMNO
operons and we speculate that this Ala-Ala motif may be a signal for the protease
ClpXP.
Subjects Biochemistry, Microbiology, Molecular Biology
Keywords Streptomyces, Antibiotics, Secondary metabolites, Actinomycetes, Gene regulation, ECF sigma
factor, Antimycin
INTRODUCTION
Approximately 60% of the antibiotics and anticancer compounds currently used in
human medicine are derived from the secondary metabolites of soil-dwelling
Streptomyces species and other filamentous actinomycetes. Although the vast majority of
these natural products were discovered more than 40 years ago, the advent of genome
mining and new tools to unlock so-called ‘‘silent’’ pathways mean that these bacteria still
oﬀer us the best hope of developing new antibiotics for clinical use. The antimycin family
of natural products were discovered nearly 65 years ago and initially attracted interest
because of their potent antifungal activity (Dunshee et al., 1949). Antimycins are widely
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produced by Streptomyces species and they exhibit a range of bioactive properties,
including antifungal, insecticidal and nematocidal activity. This is the result of their
ability to inhibit cytochrome c reductase, an enzyme in the respiratory chain in bacteria
and mitochondria. Antimycins are also used as piscicides (brand name Fintrol R⃝) to kill
oﬀ unwanted scaled fish in the farming of catfish, which are relatively insensitive to
antimycins (Finlayson et al., 2002). More recently antimycins have been shown to be
potent and selective inhibitors of the mitochondrial Bcl-2/Bcl-xL-related anti-apoptotic
proteins which are over-produced by drug resistant cancer cells. Over-production of
Bcl-2/Bcl-xL proteins in cancer cells confers resistance to multiple chemotherapeutic
agents whose primary mode of action is to trigger apoptosis. Antimycins bind to the
hydrophobic groove of Bcl-2-type proteins and inhibit their activity in a mechanism of
action that is independent of their activity against electron transport (Tzung et al., 2001).
A synthetic derivative of antimycin A3, 2-methoxyantimycin A3 (2-MeAA), no longer
inhibits the respiratory chain, but retains potent antagonistic activity toward Bcl-2-related
proteins and induces apoptosis (Tzung et al., 2001; Schwartz et al., 2007 ). This has led to
suggestions that antimycin derivatives such as 2-MeAA could be used alongside
traditional apoptosis-inducing chemotherapeutics to block drug resistance and kill
cancer cells. There is significant interest in bioengineering antimycins with improved
pharmacological properties for the treatment of cancer and infectious diseases.
Despite their unique chemical structure and important biological properties, the
antimycin biosynthetic pathway was only reported very recently (Seipke et al., 2011a,
Seipke et al., 2011b) and rapid progress has been made in elucidating the biosynthetic
steps in this pathway over the last two years (for a recent review see Seipke & Hutchings,
2013). Antimycins are produced by a hybrid non-ribosomal peptide synthetase
(NRPS)/polyketide synthase (PKS) assembly line for which the complete biosynthetic
pathway has been proposed (Sandy et al., 2012; Yan et al., 2012). The AntFGHIJKLN
proteins encode the biosynthetic pathway for the unusual starter unit,
3-aminosalicylate-CoA (Schoenian et al., 2012; Sandy et al., 2012). The AntCD proteins
comprise the hybrid NRPS/PKS machinery, and AntE and AntM are crotonyl-CoA
reductase and discrete ketoreductase homologues, respectively (Sandy et al., 2012). AntO
and AntB are tailoring enzymes. AntO is predicted to install the N -formyl group (Yan
et al., 2012; Sandy et al., 2012), and AntB is a promiscuous acyltransferase that catalyses a
transesterification reaction of a hydroxl group at C-8 to result in the acyloxyl moiety and
the chemical diversity observed at R1 (Sandy et al., 2013). The antA gene encodes an
extracytoplasmic function (ECF) RNA polymerase sigma (σ ) factor named σAntA which,
like all other ECF σ factors, contains only two of the four σ 70 domains (Staron et al.,
2009).
The resurgence of interest in the biosynthesis of antimycins and particularly in
engineering new analogues with better pharmacological properties led us to investigate
the transcriptional organisation and regulation of the antimycin gene cluster. The only
regulator encoded by the ant gene cluster is σAntA, but regulation of secondary
metabolite clusters by ECF σ factors is unusual and has not yet been reported in
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Streptomyces species. To our knowledge only two examples of ECF σ factor regulation of
antibiotic biosynthesis have been described and both diﬀer from σAntA because they are
co-encoded with, and regulated by, anti-σ factors whereas σAntA is an orphan, i.e., it has
no co-encoded anti-σ factor. The two known examples both control lantibiotic
production in rare actinomycetes. InMicrobospora corallina, the pathway specific
regulator MibR and the ECF σMibX regulate microbisporicin biosynthesis and σMibX is
regulated by MibW (Foulston & Bibb, 2010). In Planomonospora alba the pathway specific
regulator PspR, the ECF sigma factor σ PspX and its anti-σ factor PspW all regulate
production of the lantibiotic planosporicin (Sherwood & Bibb, 2013). The closest
homologues to σMibX and MibW are σ PspX and its anti-σ factor PspW, suggesting a
common mechanism of regulation for these lantibiotics.
Here we characterize the gene organization of the antimycin gene cluster and the role
of σAntA in Streptomyces albus S4. We report that σAntA is regulated at the transcriptional
level and controls production of the unusual precursor 3-aminosalicylate that is required
for antimycin production. We also show that σAntA represents a new sub-family of ECF
σ factors that are only found in the ant gene clusters of Streptomyces species and provide
evidence that suggests σAntA regulation of the divergent antGF and antHIJKLMNO
operons is conserved in all antimycin producing strains. Finally we provide preliminary
evidence that the activity of σAntA is aﬀected by the two C-terminal amino acid residues
such that altering the natural Ala-Ala residues to Asp-Asp increases expression of the
σAntA target genes. Since a C-terminal Ala-Ala motif is a well known signal for the serine
protease ClpXP (Flynn et al., 2003) this may provide a novel post-translational
mechanism for controlling σAntA activity without the need for an anti-σ factor.
MATERIALS AND METHODS
Growth media and strains. Streptomyces strains (Table 1) were grown on mannitol-soya
flour (MS) agar and Lennox broth (LB) (Kieser et al., 2000), and Escherichia coli strains
(Table 1) were grown on LB or LB agar. Growth media was supplemented with antibiotics
as required at the following concentrations: apramycin (50 µg/ml), carbenicillin (100
µg/ml), hygromycin B (50 µg/ml), kanamycin (50 µg/ml), nalidixic acid (50 µg/ml). All
Streptomyces strains were created using cross-genera conjugation in which DNA was
transferred from E. coli ET12567/pUZ8002 (MacNeil et al., 1992) according to standard
methods (Kieser et al., 2000).
Cosmid library construction and screening. A Supercos1 cosmid library was constructed
from Streptomyces albus S4 genomic DNA partially digested with Sau3AI and packaged
into Gigapack III XL phage according to the manufacturer’s instructions (Agilent
Technologies). One thousand cosmid clones were screened by PCR using primers RFS172
and RFS173 (Table S2), which target an internal fragment of the antC gene. Cosmid 456
and cosmid 213 tested positive and were end-sequenced using primers RFS184 and
RFS185 (Table S2) and mapped onto the Streptomyces albus S4 genome using BLAST
2.2.23+ (Altschul et al., 1990).
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Table 1 Strains, cosmids and plasmids used in this study.
Strain Reference
S4 Wild type Streptomyces albus S4 Barke et al., 2010
S4"antA S4 antA null mutant; AprR This study
S4 antA attB
#BT1::pIJ10257-antA
Complemented antA null mutant; antA transcription driven by the ermE* promoter;
AprR, HygR
This study
S4"antA attB
#BT1::pAU3-45-antA-AA
Complemented antA null mutant; antA driven its native promoter; AprR TspR This study
S4"antA attB
#BT1::pAU3-45-antA-DD
Complemented antA null mutant with mutations A172D A173D with antA driven
its native promoter; AprR TspR
This study
S4"antC S4 antC null mutant; AprR This study
S4"STRS4_02194 S4 STRS4_02194 null mutant; AprR This study
S4"STRS4_02195 S4 STRS4_02195 null mutant; AprR This study
S4"STRS4_02212 S4 STRS4_02212 null mutant; AprR This study
S4"STRS4_02213-02217 S4 STRS4_02213-02217 null mutant; AprR This study
Escherichia coli
BL21 Host for heterologous protein expression Novagene
BW25113 Host for REDIRECT PCR targeting system Gust et al., 2003
DHM1 Host for Cya bacterial two hybrid system Karimova et al., 1998
ET12567 Non-methylating host for transfer of DNA into Streptomyces spp. (dam, dcm, hsdM);
CamR
MacNeil et al., 1992
TOP10 General cloning host Invitrogen
VCS257 Host strain for Gigapack III XL phage Agilent Technologies
Cosmids
Supercos1 Cosmid backbone for S. albus S4 cosmids; AmpR, KanR Stratagene
Cosmid 213 Supercos1 derviative containing the entire antimycin gene cluster; AmpR, KanR This study
Cosmid 213"antB-flp Cosmid 213 derivative containing an 81 bp scar in place of the antB gene This study
Cosmid 456 Supercos1 derviative containing a portion of the antimycin gene cluster; AmpR,
KanR
This study
Plasmids
pCRII-TOPO Cloning vector for PCR products; AmpR, KanR Invitrogen
pAU3-45 pSET152 derivative, integrates into#C31 attB site in Streptomyces; AprR TspR Bignell et al., 2005
pAU3-45-antA-AA pAU3-45 derivative containing the antA gene, an 81 bp ‘scar’ in place of antB, and
270 bp upstream of antB cloned into the EcoRI site
This study
pAU3-45-antA-DD pAU3-45 derivative containing the antA gene encoding A172D and A173D muta-
tions, an 81 bp ‘scar’ in place of antB, and 270 bp upstream of antB, cloned into the
EcoRI site
This study
pET28a Protein expression vector; KanR Novagene
pET28a-antA pET28a derivative containing the antA coding sequence cloned into the NdeI and
HindIII sites
This study
pGEM-T Easy Cloning vector for PCR products; AmpR Promega
pIJ773 PCR template for aac3(IV)+ oriT cassette used in REDIRECT PCR targeting system Gust et al., 2003
pIJ790 Encodes lambda RED recombination machinery induced by arabinose; CamR Gust et al., 2003
pIJ10700 PCR template for hygR cassette used in REDIRECT PCR targeting system Gust et al., 2003b
pIJ10257 pMS81 derivative containing ermE*p, integrates into the #BT1 attB site in Strepto-
myces; HygR
Hong et al., 2005
pIJ10257-antA pIJ10257 derivative containing the antA coding sequence cloned into the NdeI-
HindIII sites
This study
pUZ8002 Encodes conjugation machinery for mobilization of plasmids from E. coli to Strepto-
myces; KanR
MacNeil et al., 1992
Notes.
Amp, ampicillin; Apr, apramycin; Hyg, hygromycin; Kan, kanamycin; Cam, chloramphenicol.
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Construction of Streptomyces albus S4mutant strains.Mutant strains were constructed
using λ-RED based PCR-targeting mutagenesis (Gust et al., 2003). A disruption cassette
consisting of a conjugal origin of transfer (oriT ) and the apramycin resistance gene,
aac(3)IV from pIJ773 (Gust et al., 2003), was generated by PCR using BioTaq polymerase
(Bioline) and oligonucleotide primers (Table S2) containing 39 nt of homology that
included the start and stop codons of each gene (with the exception of the
STRS4_02213-02217 multi-mutant) and 36 nt upstream or downstream of the open
reading frame. The resulting PCR products were gel purified and electroporated into
E. coli BW25113/pIJ790 harboring either cosmid 456 ("STRS4_02194,"STRS4_02195,
"antA,"antC) or cosmid 213 ("STRS4_02222,"STRS4_02213-STRS4_02217 ).
Transformants were screened for the presence of mutagenised cosmid by NotI digestion.
Mutagenised cosmids were moved to S. albus S4 by conjugation. Transconjugants were
selected for apramycin resistance and kanamycin sensitivity. The integrity of mutant
strains was verified by PCR using flanking primers for each deleted coding sequence
together and in combination with the P1 and P2 primers which target the apramycin
cassette (Gust et al., 2003). Combinations RRF228 and 229, RRF278 and 279 and RRF329
and 330 were used to test the 02194, 02195 and 02212 knockouts, respectively (Table S2).
Construction of plasmids. In order to heterologously express and purify AntA, the antA
coding sequence was PCR-amplified from genomic DNA using oligonucleotide primers
engineered to possess NdeI and HindIII restriction sites (RFS230 and RFS 231, Table S2)
using Phusion polymerase (New England Biolabs). The resulting PCR product was gel
purified and digested with NdeI and HindIII (Roche) and ligated with pET28a
(Novagene) cut with the same enzymes using T4 DNA ligase (Promega) to create
pET28a-antAI. DNA sequencing using the T7 promoter and T7 terminator primers
(Novagene) verified the integrity of the cloned antA coding sequence. In order to
construct the antA over-expression/complementation plasmid, pIJ10257-antA, the antA
coding sequence was excised from pET28a-antA using NdeI and HindIII and ligated to
pIJ10257 (Hong et al., 2005) cut with the same enzymes. pIJ10257-antA was introduced
into Streptomyces strains by conjugation and transconjugants were selected for resistance
for hygromycin.
In order to generate complementation constructs in which transcription of wild-type
and mutated antA was initiated by its native promoter, we replaced the antB gene with an
apramycin resistance cassette using the REDIRECT system described above using oligos
RFS188 and RFS189 (Gust et al., 2003, Table S2). The apramycin cassette possesses two
FRT sites recognised by the FLP recombinase. The mutagenised cosmid was introduced
into E. coli strain BT340, which expresses a FLP recombinase when cultured at 42◦C
(Gust et al., 2003). FLP recombinase-mediated excision of the apramycin resistance
cassette leaves an 81 bp in-frame ‘‘scar.’’ Cosmid 213"antB-flp was used as template for
PCR with the forward primer RFS351 and the reverse primers RFS231 or RFS352 (Table
S2). RFS351 targets 270 bp upstream of the putative antB start codon, and RFS231 and
RFS352 both target an identical sequence in the C-terminus of antA, with the exception
that RFS352 introduces two C→ A point mutations, which introduces A172D and
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A173D changes into the resulting AntA protein. These PCR products were cloned into
pGEMT-Easy (Promega) and verified by DNA sequencing using M13R and M13F
oligonucleotides. Next, the antA-containing inserts were excised from pGEMT-Easy by
EcoRI digestion and ligated with pAU3-45 (Bignell et al., 2005) digested with the same
enzyme. pAU3-45-antA-AA and pAU3-45-antA-DD were introduced into Streptomyces
strains by conjugation and transconjugants were selected for resistance to thiostrepton.
Phylogenetic analysis. Antimycin gene clusters were analysed from S. ambofaciens ATCC
23877 (AM238663, (Choulet et al., 2006)), S. blastmyceticus NBRC 12747 (AB727666,
(Yan et al., 2012)), S. gancidicus BKS 13-15 [AOHP00000000, (Kumar et al., 2013), S.
griseoflavus Tü4000 (ACFA00000000), S. hygroscopicus subsp. jinggangensis 5008
(NC_017765), S. hygroscopicus subsp. jinggangensis TL01 (NC_020895), Streptomyces sp.
303MFCol5.2 (ARTR00000000), Streptomyces sp. TOR3209 (AGNH00000000, (Hu et al.,
2012) S. albus S4 (CADY00000000, (Seipke et al., 2011b)), S. albus J1074 (NC_020990),
Streptomyces sp. SM8 (AMPN00000000), Streptomyces sp. NRRL2288 (JX131329), (Yan
et al., 2012)), Streptomyces sp. LaPpAH-202 (ARDM00000000), Streptomyces sp. CNY228
(ARIN01000033). σAntA proteins were aligned to five (when possible) random proteins
from each ECF RNA polymerase σ factor subfamily defined by Staron et al (Staron et al.,
2009) by using Clustal (Sievers et al., 2011). The phylogenetic tree was created using
PhyML 3.0 with the default settings (Guindon et al., 2010) and visualised using FigTree
v1.4 (http://tree.bio.ed.ac.uk/software/figtree/).
HPLC analysis.Wild-type and mutant strains were cultured atop a cellophane disc on MS
agar. At the time of harvest, the cellophane disc containing mycelia was removed and
either processed for RNA extraction (below) or discarded. Bacterial metabolites were
extracted from the spent agar using 50 ml of ethyl acetate for 1 h. 20 ml of ethyl acetate
was evaporated to dryness under reduced pressure and the resulting residue was
resuspended in 400 µl 100% methanol. In all cases, the methanolic extracts from at least
two biological replicates were mixed and centrifuged at>16,000 g in a microcentrifuge
prior to analysis. Antimycin A1–A4 standards were purchased from Sigma-Aldrich. 35 µl
of methanolic extract was separated on a Phenomenex C18(2) 5 µm 4.6× 150 mm using
a Hitachi L-6200 HPLC system and the following gradient (solvent A: water, solvent B:
methanol, flow rate 1 ml/min): 0–20 min, 10–100% B; 20–34 min 100% B; 34.1–44 min,
10% B. Samples were analysed with a Shimadzu M20A Photo Diode Array.
RNA analysis. For all experiments involving RNA, S. albus S4 strains were cultivated at
30◦C on MS agar atop a cellophane disc to facilitate the easy harvest of mycelia into
microcentrifuge tubes. Transcription was arrested using a stop solution (95% ethanol, 5%
acid phenol) diluted 1:4 with water. Total RNA was extracted using a RNeasy Mini Kit
(Qiagen) according to the manufacturer’s instructions and included both an on-column
and a post-column DNaseI treatment. The absence of DNA contamination was assessed
by PCR. DNase-treated RNA was reverse transcribed using 250 µg of random hexamers
and Superscript III reverse transcriptase (RT, Invitrogen) with an extension temperature
of 55◦C.
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For co-transcription analysis, twenty-nine cycles of PCR amplification with six primer
sets (Table S2) were performed using cDNA originating from 5 µg of RNA with BioTaq
Polymerase (Bioline). Primer sets were designed to span the intergenic regions of the
antimycin cluster and targeted at least 300 bp upstream of putative start codons to
account for promoters driving transcription from multiple sites within a transcriptional
unit. RNA from the complemented antAmutant strain ("antA/pIJ10257-antA) was used,
because transcript abundance was greater for operons involved in 3-aminosalicylate
biosynthesis. The PCR products obtained were cloned into either pCRII-TOPO
(Invitrogen) or pGEM-T Easy (Promega) and sequenced by either the Genome Analysis
Centre (Norwich, UK), Source BioScience (Cambridge, UK), or Eurofins MWGOperon
(Ebersberg, Germany) using oligonucleotide primer M13r (Integrated DNA
Technologies).
For quantitative RT-PCR, gene-specific primers were designed to amplify∼100 bp
from the first and last gene of each transcriptional unit in the antimycin cluster. cDNA
was diluted (1 volume of cDNA to 2 volumes of water) and target genes were quantified
using a Bio-Rad CFX96TM instrument and SensiFastTM SYBR No-ROX kit (Bioline).
Each treatment consisted of three biological replicates and two technical replicates. The
calculated Ct (threshold cycle value) for each target gene was normalized to the Ct
obtained for the hrdB gene, which encodes the vegetative sigma factor and is routinely
used as a reference gene for transcriptional analyses (Kelemen et al., 1996).
For mapping of transcriptional start sites, 10 µg of RNA from the
"antA/pIJ10257-antA strain was processed using the FirstChoice R⃝ RLM-RACE Kit
(Ambion) according to the manufacturer’s instructions with the following modifications:
for cDNA synthesis, Superscript III RT (Invitrogen) was used to according the
manufacturer’s instructions using an extension temperature of 55◦C. The gene-specific
primers used for each transcriptional unit are listed in Table S2. The final PCR products
were gel purified and cloned into pCRII-TOPO (Invitrogen) or pGEM-T Easy (Promega)
and sequenced using oligonucleotide primers M13r (Integrated DNA Technologies) by
either the Genome Analysis Centre (Norwich, UK), Source BioScience (Cambridge, UK)
or Eurofins MWGOperon (Ebersberg, Germany). The transcriptional start site was
determined to be the nucleotide immediately adjacent to the sequence of the
5′RLM-RACE RNA adapter.
Bacterial two-hybrid analysis. The full STRS4_02195, AntA, and STRS4_04339 (SigB
orthologue) coding sequences were PCR-amplified from S4 genomic DNA using Phusion
Polymerase (New England Biolabs) and primers RFS280 and RFS281 (STRS4_02195),
RFS282 and RFS283 (antA), and sigB (RFS284 and RFS285) (Table S1). The gel purified
PCR products were digested with BamHI and KpnI (Roche) and cloned into bacterial
two-hybrid plasmids pUT18C and pKT25 (Karimova et al., 1998) cut with the same
enzymes. Cloned inserts were sequenced by The Genome Analysis Centre (Norwich, UK)
using primers RFS286, RFS287 (pUT18C clones) and RFS288 and RFS289 (pKT25
clones) to ensure that no mutations had occurred. Plasmid combinations of interest were
co-electroporated into E. coli DHM1 and processed for β-galactosidase activity as
previously described (Hutchings et al., 2002).
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RESULTS AND DISCUSSION
Organisation and expression of the antimycin gene cluster
To facilitate mutagenesis of the antimycin gene cluster, we constructed a Supercos1
library of the S. albus S4 genome (Genbank accession CADY00000000.1) and screened
the library by PCR against an internal fragment of antC.We identified two overlapping
cosmids containing antC and confirmed that cosmid 213 contains the complete predicted
ant gene cluster by deleting genes adjacent to the cluster using PCR-targeted mutagenesis
(Fig. 1). To define the upstream border we deleted STRS4_02194, which encodes a
separate NRPS and STRS4_02195 which encodes a predicted membrane protein of
unknown function. To determine the downstream border we deleted STRS4_02212 and
STRS4_02214-STRS4_02217 which are predicted to encode a nitrate/nitrite assimilation
protein and an ABC-transport system, respectively. To determine if these mutations aﬀect
antimycin production we performed bioassays against the human pathogen Candida
albicans and observed no obvious diﬀerence in the ability of the S. albus S4 strains to
inhibit the growth of C. albicans compared to wild-type (Fig. 2A). High performance
liquid chromatography (HPLC) confirmed that antimycin production is not aﬀected by
any of these mutations showing that STRS4_02194, STRS4_ 02195, STRS4_02212, and
STRS4_02214-02217 mark the boundaries of the ant gene cluster (Fig. 2B). The gene
organization of the ant cluster suggests there is a minimum of four transcriptional units
with the largest being the antHIJKLMNO operon (Fig. 1). Almost all of these ORFs
overlap, suggesting transcriptional and translational coupling, but as a proof of principle
we confirmed that the antGF and antHIJKLMNO genes are co-transcribed by performing
end-point RT-PCR. Six primer pairs were designed to span the intergenic (or overlapping
gene) regions of the antGF and antHIJKLMNO operons and targeted at least 300 bp
upstream of the putative start codons to detect transcriptional read-through. Six PCR
products were obtained by RT-PCR analysis and sequenced to confirm that antGF and
antHIJKLMNO form two operons. No products were obtained when reverse transcriptase
was omitted (Fig. S1). In addition to confirming that antGF and antHIJKLMNO are
organized into operons, this also validates our approach to analysing their expression
using qRT-PCR to measure mRNA levels of the first and last genes in each operon.
Streptomyces species have a complex life cycle that includes growth as a substrate
mycelium that gives rise to aerial mycelia and sporulation. To determine at which stage of
the life cycle the antimycin gene cluster is expressed we measured expression of the four
ant operons after 18 and 42 h growth on mannitol-soya flour (MS) agar. After 18 h
growth on MS agar S. albus S4 consists entirely of substrate mycelium but after 42 h the
substrate mycelium has diﬀerentiated to produce aerial mycelium and spores. All four ant
operons are expressed at a significantly higher level at 18 h (in substrate mycelium)
compared to 42 h which suggests that all four ant operons are switched oﬀ following
diﬀerentiation (Fig. 3A). Conversely, HPLC analysis of mycelium and culture medium
extracted at the same time points only detected antimycins in the 42 h samples suggesting
there is a lag between ant gene expression and antimycin production (Fig. 3B). This is
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Figure 1 The antimycin biosynthetic gene cluster in Streptomyces albus S4.Genes shaded grey indicate
those that are required for antimycin biosynthesis. Genes shaded black were experimentally determined
not to be required for antimycin biosynthesis. Narrow black arrows indicate the presence of four operons
and the direction of their transcription. The locations of cosmid 213 and cosmid 456 are indicated by
horizontal lines and the double vertical hash indicates that cosmid 456 is comprised of additional DNA
that falls outside the boundaries of this schematic.
probably due to the time it takes for the precursor to be produced and for the antimycin
scaﬀold to be assembled and then accumulate to detectable levels. Most notably, these
data suggest that specific regulatory mechanisms exist to activate ant gene expression in
substrate mycelium and switch it oﬀ again following diﬀerentiation. Since antA is the
only putative regulatory gene in the ant gene cluster we investigated the role of σAntA in
regulating antimycin production.
Antimycin production is dependent on the orphan ECF sigma factor
σAntA
To investigate the role of σAntA in regulating antimycin biosynthesis, we deleted the antA
gene and tested the mutant strain against C. albicans in a bioassay.The antAmutant is
significantly less active against C. albicans compared to wild-type and this is consistent
with loss of antimycin production (Seipke et al., 2011a). Complementation of this mutant
with the antA gene under the control of the strong constitutive ermE* promoter restores
bioactivity against C. albicans to wild-type levels (Fig. 4A) and HPLC analysis confirmed
that antimycins are not produced by the antAmutant (Fig. 4B). We conclude that σAntA is
required for antimycin production.
To determine which of the four ant promoters are regulated by σAntA we used
qRT-PCR to measure ant operon expression in the wild-type and antA strains grown for
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Figure 2 Defining the boundaries of the antimycin gene cluster. (A) Streptomyces albus S4WT andmu-
tant strains challenged withCandida albicans.Null mutants of genes adjacent to the gene cluster (coloured
black in Fig. 1) produce an antimycin-positive phenotype, characterised by a large circular zone of cleared
C. albicans growth. The"antC mutant strain displays an antimycin-negative phenotype, but retains resid-
ual antagonistic activity against C. albicans due to the production of candicidin, a second antifungal com-
pound produced by this strain (Barke et al., 2010; Seipke et al., 2011a). (B) High-performance liquid chro-
matography (HPLC) of metabolites produced by S. albus S4 WT and mutant strains. The"antC mutant
does not produce antimycins, while null mutations in genes adjacent to the antimycin cluster had no eﬀect
on antimycin production.
18 h on MS agar. Deletion of antA did not aﬀect the level of transcription of either the
antBA or antCDE operons, but transcription of both the antGF and antHIJKLMNO
operons was significantly reduced in the antAmutant (Fig. 5). This suggests that σAntA
positively regulates the transcription of the antFGHIJKLMNO genes which encode
biosynthesis of 3-aminosalicylate, the precursor used by the AntC NRPS. Furthermore,
over-expression of σAntA in 42 h cultures activates the expression of the antGF and
antHIJKLMNO operons leading us to conclude that no additional regulators are required
to activate the antG and antH promoters (Fig. 6). In addition the antB and antC
promoters must be regulated by a transcription factor encoded outside of the ant gene
cluster since they are upregulated at 18 h relative to 42 h growth. To confirm this we
introduced cosmid 213 into S. lividans, S. coelicolor M145 and the S. coelicolor superhost
strains M1146, M1152 and M1154 (Gomez-Escribano & Bibb, 2011) but failed to detect
antimycin production, supporting the idea that at least one additional transcription
activator is required.
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Figure 3 There is a delay between expression of the antimycin biosynthetic genes and the produc-
tion of antimycins. (A) HPLC analysis of metabolites produced by S. albus S4 wild-type. Antimycins are
detected in media extracts of 42 h old but not 18 h old cultures. (B) qRT-PCR analysis of the antimycin
gene cluster in 18 and 42 h old cultures shows that expression of the antimycin gene cluster is significantly
down-regulated following diﬀerentiation. *** denote that values reported are statistically significantly dif-
ferent with a P value< 0.001 in a Student’s T-test.
σAntA and its putative binding site are highly conserved
Bioinformatic analysis failed to identify the common ECF σ factor promoter motifs
upstream of the antG and antH genes, notably the ‘‘AAC’’ motif in the−35 region and
the ‘‘CGT’’ motif in the−10 region (Staron et al., 2009). We therefore mapped the
transcriptional start sites of the antGF and antHIJKLMNO operons using 5′-RLM RACE
and identified−10 and−35 regions which share high nucleotide sequence identity with
one another, but not with the σAntA-independent antB promoter (Fig. 7A). Six antimycin
producing Streptomyces strains have been reported previously (Riclea et al., 2012; Seipke
et al., 2011a; Yan et al., 2012) and we identified eight more putative antimycin gene
clusters whilst searching for σAntA orthologues in Genbank (Table S1 and Experimental
Procedures). Since the 14 known σAntA orthologues share 66% sequence identity (Table
S1, Fig. S2), we hypothesise that σAntA regulation of the antG and antH promoters will be
common to all antimycin producing Streptomyces strains. To investigate this, we searched
for the antG and antH promoter motifs in the 14 known or predicted antimycin gene
clusters encoded by published Streptomyces genome sequences. All 14 antG promoters
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Figure 4 σAntA is required for the biosynthesis of antimycins. (A) S. albus S4 strains challenged with
Candida albicans. The"antA null mutant shows dramatically reduced bioactivity compared to the wild-
type strain and the complemented strain ("antA/pIJ10257-antA). The residual bioactivity of the "antA
mutant is due to the continued production of candicidin, a second antifungal compound. (B) HPLC anal-
ysis of metabolites produced by S. albus S4 strains. Antimycins were only detected in extracts prepared
from the wild-type and the"antA/pIJ10257-antA strains, and not the"antA null mutant.
contain very high sequence identity in the−35 and−10 regions, although S. ambofaciens
has an 18 nucleotide spacer between the−35 and−10 element compared to the typical
17 nucleotide spacer (Fig. 7B). High nucleotide conservation was also observed at the
antH promoter and the−10 element contains a ‘‘CTC’’ motif that is 100% conserved
across all promoters although again spacer regions between the−10 and−35 elements
vary in length between 17 and 18 bp (Fig. 7B). The in silico data therefore suggests that
σAntA has highly conserved−35 and−10 binding sites at the antG and antH promoters
of all antimycin producing Streptomyces strains. Scanning the complete published S. albus
genome with the AntA−10 and−35 binding sites (using GLEME2 – part of MEME)
returns only two significant hits, the antGF and antHIJKLMNO promoters suggesting
there are no other σAntA targets (results not shown) (Bailey et al., 2009). This strongly
suggests that σAntA is a pathway-specific regulator of antimycin biosynthesis.
σAntA represents a new sub-family of ECF sigma factors
σAntA contains only the σ2 and σ4 domains (Pfam families PF04542 and PF08281) which
is characteristic of the ECF family of RNA polymerase σ factors (Staron et al., 2009).
However, σAntA does not fit into any of the ECF sub-families listed in the
well-maintained public database ECF Finder (Staron et al., 2009). Multiple sequence
alignments of the 14 σAntA homologues in the database and representatives of all known
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Figure 5 σAntA activates transcription of the antFG and antHIJKLMNO operons. qRT-PCR analysis
of antimycin genes in the wild-type and"antA strains after 18 h growth. Transcription of antFG and an-
tHIJKLMNO is significantly reduced in the"antAmutant strain, whereas transcription of antBCDE are
unaﬀected. *** denote that values reported are statistically significantly diﬀerent in a Student’s t test with
a P value< 0.001 in a Student’s T-test.
Figure 6 σAntA alone is suﬃcient to activate transcription of antFG and antHIJKLMNO in 42 h old
cultures. qRT-PCR analysis of wild-type or"antA/pIJ10257-antA in 42 h old cultures shows that repres-
sion of σAntA-regulated genes can be overcome by over-expressing antA.
ECF sub-families revealed that the σAntA proteins form a distinct clade and therefore
represent a new sub-family of ECF σ factors (Table S1 and Fig. S3). ECF σ factors are rare
in secondary metabolite gene clusters and to our knowledge this is the first example in
Seipke et al. (2014), PeerJ, 10.7717/peerj.253 13/18
Figure 7 Identification of σAntA promoter motifs. (A) The −10 and −35 motifs at the σAntA-target
promoters of antFG and antHIJKLMNO are nearly 100% identical and display zero nucleotide identity
with the promoter region of antAB. Shared identity is indicated by grey shading. The nucleotides mapped
by 5′RLM-RACE is denoted by+1 and are shown in bold face (B) Conservation of the S. albus S4 antFG
and antHIJKLMNO promoter elements in other antimycin-producing Streptomyces species. Conserva-
tion between the experimentally determined promoter region of S. albus S4 and the putative promoter
regions of other antimycin producers is indicated by grey shading. (C) Consensus sequence for the −35
and−10 promoter elements recognised by σAntA displayed as aWebLogo (Crooks et al., 2004). Below are
the full strain names and accession numbers for antimycin-producing strains: S. ambofaciensATCC23877
(AM238663), S. blastmyceticus NBRC 12747 (AB727666), S. gancidicus BKS 13-15 (AOHP00000000), S.
griseoflavus T4000 (ACFA00000000), S. hygroscopicus subsp. jinggangensis 5008 (NC017765), S. hygro-
scopicus subsp. jinggangensisTL01 (NC020895), Streptomyces sp. 303MFCol5.2 (ARTR00000000), Strepto-
myces sp. TOR3209 (AGNH00000000), S. albus S4 (CADY00000000), S. albus J1074 (NC020990), Strepto-
myces sp. SM8 (AMPN00000000), Streptomyces sp. NRRL2288 (JX131329), Streptomyces sp. LaPpAH-202
(ARDM00000000), Streptomyces sp. CNY228 (ARIN00000000).
Streptomyces species (Foulston & Bibb, 2010; Sherwood & Bibb, 2013). The only obvious
candidate for an anti-σAntA factor in the antimycin gene cluster is the putative membrane
protein STRS4_02195. However, it is absent from the ant clusters in other streptomycetes,
its removal has no eﬀect on antimycin biosynthesis (Fig. 2) and it does not interact with
σAntA in bacterial two-hybrid analysis (Fig. S4) which leads us to conclude that σAntA is
an orphan ECF that is not subject to anti-σ factor control. However, since antA
expression is activated in substrate mycelium (by an as yet unknown regulator) and
switched oﬀ following diﬀerentiation we predict that a mechanism might exist to remove
σAntA protein at this stage of growth. The only unusual feature in the primary sequence of
the 14 σAntA homologues is the conserved C-terminal Ala-Ala (AA) motif (Fig. S2)
which is a known signal for the serine protease ClpXP (Flynn et al., 2003). To test whether
the C-terminal AA residues are required for σAntA activity we made two identical
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Figure 8 Altering the terminal Ala-Ala motif of σAntA results in higher expression of σAntA targets.
The "antA null mutant was complemented with either a wild-type copy of antA or a variant of antA
encoding A172D and A173D point mutations. After 42 h of growth, transcription of σAntA-targets in the
"antA/antA-DD strain were significantly greater than both the wild-type and "antA/antA-AA strains,
suggesting the terminal Ala-Ala motif modulates stability and/or activity of σAntA. ** and *** denote that
values reported are statistically significantly diﬀerent with a P value< 0.01 and 0.001 in a Student’s T-test,
respectively.
constructs expressed under the control of the native antB promoter. The first construct
drives production of the wild-type protein (designated σAntA−AA) and the second drives
production of an altered protein in which the AA has been replaced with DD (designated
σAntA−DD). We introduced these constructs into the antAmutant and measured
expression of the antGF and antHIJKLMNO operons in these strains. Both operons are
significantly more highly expressed in the strain producing σAntA−DD compared with the
wild type σAntA−AA protein (Fig. 8). These data suggest that the two C-terminal residues
play an important role in the stability and/or activity of σAntA and may target σAntA for
proteolysis by ClpXP. Unfortunately, all attempts to detect the σAntA protein by
immunoblotting whole cell extracts with polyclonal anti-σAntA antibodies have been
unsuccessful while tagging the protein at the N-terminus inactivates the protein (not
shown). Future work will therefore be required to determine the role of the C-terminal
AA motif in σAntA however, we have provided preliminary evidence that suggests σAntA
might be a direct target for ClpXP, thereby bypassing the requirement for the additional
level of anti-σ regulation. This would also provide a rapid mechanism to shut down
precursor biosynthesis when antimycins are no longer required.
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